Trial · NCT01430442
Adverse events40
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 40
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | NAUSEA | Gastrointestinal disorders | Treatment A: Rimegepant, 10 mg | 1 | 72 | 1 |
| other | NAUSEA | Gastrointestinal disorders | Treatment B: Rimegepant, 25 mg | 0 | 62 | 0 |
| other | NAUSEA | Gastrointestinal disorders | Treatment C: Rimegepant, 75 mg | 3 | 86 | 3 |
| other | NAUSEA | Gastrointestinal disorders | Treatment D: Rimegepant, 150 mg | 3 | 86 | 3 |
| other | NAUSEA | Gastrointestinal disorders | Treatment E: Rimegepant, 300 mg | 5 | 112 | 5 |
| other | NAUSEA | Gastrointestinal disorders | Treatment F: Rimegepant, 600 mg | 7 | 84 | 7 |
| other | NAUSEA | Gastrointestinal disorders | Treatment P: Rimegepant Placebo-Matching Capsules | 5 | 209 | 5 |
| other | NAUSEA | Gastrointestinal disorders | Treatment G: Sumatriptan 100 mg | 2 | 100 | 2 |
| other | DIARRHOEA | Gastrointestinal disorders | Treatment A: Rimegepant, 10 mg | 4 | 72 | 4 |
| other | DIARRHOEA | Gastrointestinal disorders | Treatment B: Rimegepant, 25 mg | 0 | 62 | 0 |
| other | DIARRHOEA | Gastrointestinal disorders | Treatment C: Rimegepant, 75 mg | 0 | 86 | 0 |
| other | DIARRHOEA | Gastrointestinal disorders | Treatment D: Rimegepant, 150 mg | 0 | 86 | 0 |
| other | DIARRHOEA | Gastrointestinal disorders | Treatment E: Rimegepant, 300 mg | 1 | 112 | 1 |
| other | DIARRHOEA | Gastrointestinal disorders | Treatment F: Rimegepant, 600 mg | 0 | 84 | 0 |
| other | DIARRHOEA | Gastrointestinal disorders | Treatment P: Rimegepant Placebo-Matching Capsules | 0 | 209 | 0 |
| other | DIARRHOEA | Gastrointestinal disorders | Treatment G: Sumatriptan 100 mg | 0 | 100 | 0 |
| serious | PNEUMONIA | Infections and infestations | Treatment A: Rimegepant, 10 mg | 0 | 72 | 0 |
| serious | PNEUMONIA | Infections and infestations | Treatment B: Rimegepant, 25 mg | 0 | 62 | 0 |
| serious | PNEUMONIA | Infections and infestations | Treatment C: Rimegepant, 75 mg | 0 | 86 | 0 |
| serious | PNEUMONIA | Infections and infestations | Treatment D: Rimegepant, 150 mg | 1 | 86 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01430442/events